WASHINGTON, D.C. – Reps. Diana DeGette (D-CO) and Bill Johnson (R-OH) introduced the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act, yesterday. The bipartisan legislation will improve patient access to podiatrists in Medicaid and improve care for patients with diabetes who need therapeutic shoes via Medicare.
Chair of key House oversight panel blasts makers of insulin for ‘band-aid approach’ to bringing down cost of the drug. ‘This is not optional. It is going to happen,’ DeGette tells execs at hearing Wednesday.
WASHINGTON, D.C. – “The system is broken,” U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s currently investigating the rising cost of insulin, told a panel of drug makers and pharmacy executives who were summoned to appear before Congress today to explain why the cost of the life-saving drug has continued to rise in recent years.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Jackie Speier (D-CA) introduced legislation today to overhaul the U.S. military’s policy on providing servicemembers and their families with family-planning counseling services and coverage for contraceptives.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Mark DeSaulnier (D-CA), Zoe Lofgren (D-CA) and Jamie Raskin (D-MD) introduced a resolution today to recognize the vital role that local journalists play in promoting good governance and accountability.
U.S. Rep. Diana DeGette, chair of the House oversight panel investigating cost of the drug, announced today
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s investigating the skyrocketing cost of insulin, announced today that all three U.S. manufacturers of insulin will be appearing before Congress next week.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today that would prevent the federal government from enforcing its prohibition on marijuana in states, such as Colorado, where it is legal for residents to possess and use the drug.
Legislation seeks to make permanent a new FDA fast-track approval process for generic forms of insulin
WASHINGTON, D.C. – A bipartisan group of lawmakers introduced legislation today seeking to bring down the cost of certain biologic drugs, such as insulin, by making it easier for drug makers to get generic versions of those drugs approved by the Food and Drug Administration.
The panel, led by U.S. Rep. Diana DeGette, to hold first hearing April 2
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s currently investigating the rising cost of insulin, announced today that her committee will hold its first of two hearings on the skyrocketing cost of the drug next Tuesday, April 2, at 10:30 a.m. ET.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Tom Reed (R-NY), the co-chairs of the Congressional Diabetes Caucus, introduced legislation today to expand access to a Medicare program that teaches patients with diabetes how to best manage their diabetes and cope with its effects.
Move follows report of several major oil and gas companies drilling in CO without necessary permits, in violation of federal law
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) today urged state leaders to investigate reports that more than a half-dozen Colorado oil and gas companies are allegedly fracking along the Front Range without the necessary permits and in violation of federal law.